Patent ID: 8623851

Claim:
A method for treating or ameliorting one or more symptoms of a bronchoconstrictive disorder comprising: providing a pharmaceutical composition packaged for single dosage administration, the composition including (i) formoterol, or a pharmaceutically acceptable salt or hydrate thereof in solution; and (ii) a steroidal anti-inflammatory agent, or a pharmaceutically acceptable salt thereof in suspension; in a pharmacologically suitable fluid comprising water that is propellant-free; the composition as formulated has an estimated shelf-life of greater than 1 month usage time at 25° C. and greater than or equal to 1 year storage time when stored at 5° C., whereby greater than 90% of the initial amount of formoterol in the compositions remains at such time; and the formoterol free base concentration is about 5 μg/mL to about 200 μg/mL, whereby the composition is formulated for direct administration to a subject in need thereof; and without dilution, directly administering an effective amount of the composition as provided to a subject in need of such treatment.